Protara Therapeutics Inc (TARA)

Finanzdaten der Protara Therapeutics Inc-Aktie (TARA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	18.82%23.32	19.63	19.08	14.76	16.59
Research and Development	25.02%16.96	13.56	13.12	9.59	10.77
Operating Income/Loss	18.82%-23.32	-19.63	-19.08	-14.76	-16.59
Net Interest Income/Expense	1.48	-	-	-	-
Nonoperating Income/Loss	10.34%1.66	1.85	1.77	1.50	1.63
	21.85%-21.67	-17.78	-17.31	-13.26	-14.96
Attributable To Parent	21.85%-21.67	-17.78	-17.31	-13.26	-14.96
Basic Average Shares	6.03%61.01	57.54	1.08	42.27	42.27
Diluted Average Shares	6.03%61.01	57.54	1.08	42.27	42.27
Basic Earnings Per Share	16.13%-0.36	-0.31	-0.38	-0.31	-0.35
Diluted Earnings Per Share	16.13%-0.36	-0.31	-0.38	-0.31	-0.35